BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 2, 2026
Home » targets

Articles Tagged with ''targets''

3D illustration of a osteoclast
Musculoskeletal

Lipid raft component stomatin as target to treat osteoporosis

July 29, 2025
No Comments
Osteoporosis involves degradation of bone throughout the body, and it already affects nearly a quarter of a billion people in the aging global population.
Read More
Brain as light bulb filament
Neurology/psychiatric

Targeting podoplanin to mitigate injury after intracerebral hemorrhage

July 29, 2025
No Comments
Intracerebral hemorrhage accounts for 10%-15% of all cases of stroke, and it is associated with particularly poor prognosis due to primary and secondary brain injury driven by neuroinflammation. This inflammation involves the activation and subsequent pyroptosis, or lytic cell death, of microglia.
Read More
Illustration of astrocytes and neurons communicating through chemical signals
Neurology/psychiatric

CHI3L1 linked to impaired neurogenesis in Alzheimer’s models

July 29, 2025
No Comments
Chitinase-3-like protein 1 (CHI3L1) is a secretory glycoprotein from the glycoside involved in the regulation of immune and inflammatory responses. In the brain, CHI3L1 is primarily produced by activated astrocytes, where it is involved in inflammatory neurotoxicity, emerging as a potential biomarker of neuroinflammatory disorders, such as Alzheimer’s disease.
Read More
Musculoskeletal

Targeting TREX1 enhances cell-free DNA degradation

July 25, 2025
No Comments
Rheumatoid arthritis is a chronic, systemic autoimmune disease characterized by systemic inflammation and progressive joint destruction. Current treatments include conventional disease-modifying antirheumatic drugs and biologics. However, long-term treatment is frequently associated with drug resistance and significant adverse effects.
Read More
Neurology/psychiatric

TREM mediates neuroinflammation and synaptic dysfunction in TBI

July 24, 2025
No Comments
Researchers from Peking University and the China-Japan Friendship Hospital have gained new insights into the role of triggering receptor expressed on myeloid cells-1 (TREM-1) in traumatic brain injury (TBI). Cerebral damage resulting from external mechanical impacts causes TBI, which is a leading cause of morbidity and mortality worldwide.
Read More
Blue cancer cell
Cancer

Research uncovers how USP15 facilitates immune evasion in colorectal cancer

July 22, 2025
No Comments
Colorectal cancer remains a prevalent and deadly form of cancer. A significant challenge to treating colorectal tumors is the creation of a suppressive tumor immune microenvironment that leads to tumor progression and resistance to immunotherapy.
Read More
3d illustration of ovarian cancer
Cancer

G-quadruplexes drive transcriptional reprogramming linked to drug resistance in ovarian cancer cells

July 22, 2025
No Comments
Cancer cells often use epigenetic changes to resist treatment, a major factor particularly in late-stage deaths from ovarian cancer. One potential epigenetic marker, DNA secondary structures known as G-quadruplexes (G4s), has recently gained attention; however, their presence and role in ovarian cancer had not been studied until now.
Read More
Colorectal cancer illustration
Cancer

tRF-3021a impairs NK cell function via MICA cleavage, promoting immune escape in colorectal cancer

July 22, 2025
No Comments
Immune evasion continues to limit the effectiveness of cancer immunotherapies. Among emerging regulatory molecules, transfer RNA-derived small RNAs (tsRNAs of 13-48 nucleotides), generated through tRNA cleavage, are gaining attention for their roles in controlling gene expression at both the transcriptional and translational levels. Recent research suggests that abnormal tsRNA expression is closely associated with the development and progression of colorectal cancer.
Read More
Colorectal cancer 3D illustration
Cancer

KLRG1-driven NK cell exhaustion drives CRC progression, study finds

July 21, 2025
No Comments
Colorectal cancer (CRC) accounts for 9.3% of cancer-related deaths worldwide. The levels of circulating immune cells in patients with CRC have been reported to undergo significant alterations, concretely in lymphocyte subsets.
Read More
Respiratory

MTMR14 downregulation aggravates COPD progression

July 21, 2025
No Comments
Chronic obstructive pulmonary disease (COPD) is a respiratory disease characterized by chronic inflammation and structural damage to the alveoli, with irreversible declined lung function. M1 pro-inflammatory macrophages mainly participate in airway inflammation and in tissue destruction, and are involved in COPD, but the mechanisms need to be elucidated.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 53 54 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 30, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing